Literature DB >> 2729268

Renal disease in hypertensive adults: effect of race and type II diabetes mellitus.

W M Tierney1, C J McDonald, F C Luft.   

Abstract

To test the hypothesis that race is a predictor of hypertensive renal disease, we examined a general medicine clinic population of 6,880 hypertensive patients who were treated for at least 1 year (mean, 5.2 years). Their mean age was 55.8 years; 70% were women, 72% were black, and 41% were diabetic (95% type II). Many were already under treatment at the time of enrollment. Their mean blood pressure at entry was 150/92 mmHg; during treatment it was 142/86 mmHg. Decreased renal function, defined as a serum creatinine greater than or equal to 2 mg/dL, developed in 18.1%. A multivariable logistic regression analysis identified diabetes, glucose control, systolic blood pressure levels, heart failure, and male gender as indicators of decreased renal function. These data suggested that glucose and blood pressure control may decrease the frequency of impaired renal function. However, when these variables were controlled, blacks still had almost twice the risk for renal dysfunction (91% greater risk) than whites (P less than 0.0001). With increasing creatinine values, the percentage of black patients increased progressively. The data draw attention to and elucidate the exceptionally high incidence of renal dysfunction in blacks with or without diabetes. Further, they may explain the inordinate numbers of blacks with hypertension requiring dialysis. Finally, these retrospective data suggest that prospective trials to test the effect of blood pressure and glucose control on the course of renal disease in hypertensive and/or type II diabetic patients are warranted.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2729268     DOI: 10.1016/s0272-6386(89)80006-x

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  10 in total

1.  Screening and prevention of chronic kidney disease.

Authors:  Errol D Crook; David O Washington; John M Flack
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

2.  "Virtual" clinical trials: case control experiments utilizing a health services research workstation.

Authors:  M G Weiner; A L Hillman
Journal:  Proc AMIA Symp       Date:  1998

3.  Genetic susceptibility to hypertension-induced renal damage in the rat. Evidence based on kidney-specific genome transfer.

Authors:  P C Churchill; M C Churchill; A K Bidani; K A Griffin; M Picken; M Pravenec; V Kren; E St Lezin; J M Wang; N Wang; T W Kurtz
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

4.  A genome scan for renal function among hypertensives: the HyperGEN study.

Authors:  A T DeWan; D K Arnett; L D Atwood; M A Province; C E Lewis; S C Hunt; J Eckfeldt
Journal:  Am J Hum Genet       Date:  2000-12-12       Impact factor: 11.025

Review 5.  Diabetic nephropathy in African-American patients.

Authors:  Errol D Crook; Sejal R Patel
Journal:  Curr Diab Rep       Date:  2004-12       Impact factor: 4.810

6.  Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  J C Chan; C K Cheung; R Swaminathan; M G Nicholls; C S Cockram
Journal:  Postgrad Med J       Date:  1993-03       Impact factor: 2.401

Review 7.  Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension.

Authors:  R I Ogilvie; E D Burgess; J R Cusson; R D Feldman; L A Leiter; M G Myers
Journal:  CMAJ       Date:  1993-09-01       Impact factor: 8.262

8.  Quantifying risk of adverse clinical events with one set of vital signs among primary care patients with hypertension.

Authors:  William M Tierney; Margaret Brunt; Joseph Kesterson; Xiao-Hua Zhou; Gil L'Italien; Pablo Lapuerta
Journal:  Ann Fam Med       Date:  2004 May-Jun       Impact factor: 5.166

9.  Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injury.

Authors:  Jan Michael Williams; Albert Sarkis; Kimberly M Hoagland; Katherine Fredrich; Robert P Ryan; Carol Moreno; Bernardo Lopez; Jozef Lazar; Francisco J Fenoy; Mukut Sharma; Michael R Garrett; Howard J Jacob; Richard J Roman
Journal:  Am J Physiol Renal Physiol       Date:  2008-10-08

Review 10.  Do calcium channel blockers have renal protective effects?

Authors:  G P Reams
Journal:  Drugs Aging       Date:  1994-10       Impact factor: 3.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.